Derepression of MicroRNA-138 Contributes to Loss of the Human Articular Chondrocyte Phenotype

Arthritis and Rheumatology

Volumn 68, Issue 2, 2016, Pages 398-409

  Seidl, Christine I ^a   Martinez Sanchez, Aida ^a   Murphy, Christopher L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; COL11A2 PROTEIN; COL2A1 PROTEIN; COL9A3 PROTEIN; COLLAGENASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MICRORNA; MICRORNA 138; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COL2A1 PROTEIN, HUMAN; COLLAGEN TYPE 2; EIF2C2 PROTEIN, HUMAN; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; MIRN138 MICRORNA, HUMAN; SP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CARTILAGE CELL; CELL DEDIFFERENTIATION; CELL LOSS; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TRANSCRIPTION INITIATION SITE; WESTERN BLOTTING; ARTICULAR CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; EXTRACELLULAR MATRIX; GENETICS; KNEE; METABOLISM; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARGONAUTE PROTEINS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHROMATIN IMMUNOPRECIPITATION; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; HUMANS; KNEE JOINT; MICRORNAS; PHENOTYPE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR;

EID: 84956821783     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39428     Document Type: Article

References (38)

1. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K., MicroRNAs and epigenetics. FEBS J 2011; 278: 1598-609.
2. Osella M, Riba A, Testori A, Cora D, Caselle M., Interplay of microRNA and epigenetic regulation in the human regulatory network. Front Genet 2014; 5: 345.
3. Ambros V., MicroRNAs: tiny regulators with great potential. Cell 2001; 107: 823-6.
4. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al., Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005; 122: 553-63.
5. De Pontual L, Yao E, Callier P, Faivre L, Drouin V, Cariou S, et al., Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet 2011; 43: 1026-30.
6. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al., MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010; 24: 1173-85.
7. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, et al., MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012; 122: 2884-97.
8. Chen K, Rajewsky N., The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007; 8: 93-103.
9. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D., microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci U S A 2008; 105: 17830-5.
10. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, et al., MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A 2011; 108: 6139-44.
11. Li S, Ran Y, Zhang D, Chen J, Li S, Zhu D., MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem J 2013; 452: 281-91.
12. Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, et al., MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev 2011; 20: 259-67.
13. Ye D, Wang G, Liu Y, Huang W, Wu M, Zhu S, et al., MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling [published erratum appears in Stem Cells 2013;31:2585-6]. Stem Cells 2012; 30: 1645-54.
14. Lafont JE, Talma S, Murphy CL., Hypoxia-inducible factor 2α is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum 2007; 56: 3297-306.
15. Thoms BL, Dudek KA, Lafont JE, Murphy CL., Hypoxia promotes the production and inhibits the destruction of human articular cartilage. Arthritis Rheum 2013; 65: 1302-12.
16. Martinez-Sanchez A, Murphy CL., MiR-1247 functions by targeting cartilage transcription factor SOX9. J Biol Chem 2013; 288: 30802-14.
17. Silver IA., Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 1975; 271: 261-72.
18. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J., The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 1996; 97: 2011-9.
19. Renard E, Poree B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, et al., Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med 2012; 90: 649-66.
20. Jensen DE, Black AR, Swick AG, Azizkhan JC., Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem 1997; 67: 24-31.
21. Thoms BL, Murphy CL., Inhibition of hypoxia-inducible factor-targeting prolyl hydroxylase domain-containing protein 2 (PHD2) enhances matrix synthesis by human chondrocytes. J Biol Chem 2010; 285: 20472-80.
22. Eyre DR., Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res 2004; 427 Suppl: S118-22.
23. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, et al., Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1β. J Biol Chem 2003; 278: 17688-700.
24. Peng H, Tan L, Osaki M, Zhan Y, Ijiri K, Tsuchimochi K, et al., ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol 2008; 215: 562-73.
25. Ghayor C, Chadjichristos C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, et al., Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J Biol Chem 2001; 276: 36881-95.
26. Nicolas M, Noe V, Ciudad CJ., Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F. Biochem J 2003; 371: 265-75.
27. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ., Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15: 1176-89.
28. Hausser J, Syed AP, Bilen B, Zavolan M., Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res 2013; 23: 604-15.
29. Forman JJ, Legesse-Miller A, Coller HA., A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008; 105: 14879-84.
30. Obernosterer G, Leuschner PJ, Alenius M, Martinez J., Post-transcriptional regulation of microRNA expression. RNA 2006; 12: 1161-7.
31. Song T, Zhang X, Wang C, Wu Y, Cai W, Gao J, et al., MiR-138 suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev 2011; 12: 1307-11.
32. Duval E, Leclercq S, Elissalde JM, Demoor M, Galera P, Boumediene K., Hypoxia-inducible factor 1α inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1α-dependent redifferentiation of chondrocytes [published erratum appears in Arthritis Rheumatol 2014;66:1394]. Arthritis Rheum 2009; 60: 3038-48.
33. Yeh YM, Chuang CM, Chao KC, Wang LH., MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer 2013; 133: 867-78.
34. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, et al., SOX9 directly regulates the type-II collagen gene. Nat Genet 1997; 16: 174-8.
35. Nakamura Y, He XJ, Kato H, Wakitani S, Kobayashi T, Watanabe S, et al., Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol 2012; 166: 64-71.
36. Dudek KA, Lafont JE, Martinez-Sanchez A, Murphy CL., Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem 2010; 285: 24381-7.
37. Ono Y, Sakai T, Hiraiwa H, Hamada T, Omachi T, Nakashima M, et al., Chondrogenic capacity and alterations in hyaluronan synthesis of cultured human osteoarthritic chondrocytes. Biochem Biophys Res Commun 2013; 435: 733-9.
38. Yan J, Zhang C, Zhao Y, Cao C, Wu K, Zhao L, et al., Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials 2014; 35: 7734-49.